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Varicella-zoster virus (VZV) encodes two multiply inserted membrane proteins, open reading frame (ORF) 39 protein (ORF39p) and
glycoprotein K (gK). The HSV-1 homologs of these proteins are believed to act in conjunction with each other during viral egress and cell–cell
fusion, and they directly influence each other's intracellular trafficking. However, ORF39p and VZV gK have received very limited study largely
due to difficulties in producing antibodies to these highly hydrophobic proteins. To overcome this obstacle, we introduced epitope tags into both
ORF39p and gK and examined their intracellular distributions in transfected and infected cells. Our data demonstrate that both ORF39p and gK
accumulate predominately in the ER of cultured cells when expressed in the absence of other VZV proteins or when coexpressed in isolation from
other VZV proteins. Therefore, the transport of VZV ORF39p and gK does not exhibit the functional interdependence seen in their HSV-1
homologs. However, during infection, the primary distributions of ORF39p and gK shift from the ER to the Golgi, and they are also found in the
plasma membrane indicating that their intracellular trafficking during infection depends on other VZV-encoded proteins. During infection,
ORF39p and gK tightly colocalize with VZV envelope glycoproteins B, E and H; however, the coexpression of ORF39p or gK with other
individual viral glycoproteins is insufficient to alter the transport of either ORF39p or gK.
© 2006 Elsevier Inc. All rights reserved.Keywords: Varicella–zoster virus; Open reading frame 39; Glycoprotein K; Intracellular localizationIntroduction
Varicella-zoster virus (VZV) is classified as an alphaherpes-
virus based largely on its growth characteristics and its ability to
establish latency in the nervous system. However, unlike herpes
simplex virus types 1 and 2 (HSV-1 and -2), and most other non-
human alphaherpesviruses, VZV induces syncytia and is highly
cell associated when grown in cultured cells indicating that its
egress pathway differs substantially from that of other
alphaherpesviruses (Arvin, 1996; Grose et al., 1979).
During herpesvirus egress, nucleocapsids acquire their initial
envelope upon budding through the inner nuclear membrane
into the perinuclear space and subsequently lose their primary
envelopes as they fuse with the outer nuclear membrane to⁎ Corresponding author. 3635 Vista Ave., FDT-8N, St. Louis, MO 63110-
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doi:10.1016/j.virol.2006.08.055release capsids into the cytoplasm (Harson and Grose, 1995;
Mettenleiter, 2002; Spear et al., 1978; Skepper et al., 2001).
Cytoplasmic capsids ultimately acquire their final envelopes by
budding into Golgi-derived membranous structures that,
accordingly, must contain the full complement of virus-encoded
membrane proteins found in the envelope of mature virions
(Gershon et al., 1994; Zhu et al., 1995). Mature virions are then
transported within vesicles to the surface of cells where they are
released upon fusion of the transport vesicles with the plasma
membrane (Johnson and Huber, 2002).
Several alphaherpesvirus envelope proteins are believed to
participate in viral egress including UL20 protein (the homolog
of VZV ORF39 protein) and glycoprotein K (gK). These
proteins are conserved in all alphaherpesviruses, but most of
what is known about them is based on the study of the HSV-1
and pseudorabies virus (PRV) homologs. In HSV-1, syncytial
mutations have been mapped to both gK and UL20 protein, and
HSV-1 or PRV unable to express either gK or UL20 protein are
not released from the cytoplasm into the extracellular space;
Fig. 1. Expression and detection of ORF39p and gK. (A) Schematic of
constructs encoding epitope-tagged forms of ORF39p and gK. In the top two
lines, the white bar represents the 240 amino acid (aa) ORF39p. To produce
ORF39-M, 25 amino acids were inserted following the last native amino acid in
the ORF39p (top line). These include the cMyc epitope (italics) and the
polyhistidine epitope (underlined). To produce ORF39-F, the 8 aa FLAG epitope
(italics) was inserted following the ORF39 start codon (second line). A non-
native leucine codon (L) was incidentally inserted following the FLAG epitope.
In the third line, the white bar represents gK, which contains 340 aa. The 24 aa
that comprise the predicted signal sequence and the subsequent 16 aa are shown.
The FLAG epitope (italics) was inserted between aa 31 and 32. (B) Immu-
noprecipitation of ORF39p and gK. Cells were transfected with ORF39-F,
ORF39-M, gK-F or no DNA, metabolically labeled (Tran35S-label) and
immunoprecipitated using either anti-FLAG or anti-cMyc MAbs. ORF39-F
migrates as a 28 kDa species and ORF39M migrates as a 30 kDa species
(bracket), and gK-F migrates as a 39 kDa species (arrow).
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that these proteins are required for the fusion of intracellular
membranes (Baines et al., 1991; Banfield and Tufaro, 1990;
Dolter et al., 1994; Fuchs et al., 1997; Mo et al., 1999). In
addition, HSV-1 gK and UL20 protein appear to be functionally
interdependent (Foster et al., 2004b). It has been shown, for
example, that these proteins depend upon one another for their
transport to post-ER compartments and that they colocalize to
the trans-Golgi network after endocytosis from the plasma
membrane. In addition, a functional link between HSV-1 gK
and UL20 protein has been demonstrated during virus mediated
cell–cell fusion (Avitabile et al., 2004; Foster et al., 2004a;
Hutchinson et al., 1992b; Melancon et al., 2004). Based on
these findings, it has been hypothesized that HSV-1 and PRV
gK and UL20 protein interact directly or indirectly during
cytoplasmic virion envelopment and viral egress.
Both VZV gK and ORF39 protein (ORF39p) are struc-
turally similar to their counterparts in HSV-1 and PRV. In
particular, they are highly hydrophobic and predicted to be
multipass transmembrane proteins (Foster et al., 2003). While it
seems likely that these proteins, like their homologs in HSV
and PRV, are involved in viral egress, the amino acid sequences
of both VZV ORF39p and gK diverge markedly from their
HSV homologs (22% and 28% identity, respectively). This,
coupled with the dissimilarity of VZV and HSV growth
properties, raises the possibility that these proteins may
function differently from their HSV homologs during viral
egress.
In this report, we describe the intracellular localizations of
VZV ORF39p and gK and examine their functional relationship
to one another. We demonstrate that ORF39p and gK remain in
the ER in the absence of other viral proteins, but accumulate in
the Golgi during infection, indicating that they are dependent
upon other VZV proteins for their intracellular trafficking.
However, unlike their homologs in HSV, their intracellular
transport to the Golgi is not mediated solely by their
coexpression. In addition, VZV ORF39p and gK tightly
colocalize with each other during infection as well as with
other VZV envelope glycoproteins, suggesting a role for
ORF39p and gK at the site of final envelopment.
Results
Expression and characterization of ORF39p and gK
containing epitope tags
Efforts to generate both polyclonal and monoclonal
antibodies to VZV ORF39p and gK have met with limited
success, presumably due to the highly hydrophobic nature of
these proteins (unpublished data). To date, only polyclonal
antibodies to VZV gK have been produced (Mo et al., 1999),
and these lack sufficient specificity to conduct detailed
localization studies (Heineman and Hall, unpublished data).
Therefore, epitope tags were incorporated into gK and ORF39p
to facilitate their detection. In the case of gK, a FLAG epitope
was inserted near its amino terminus (gK-F), but following aa
31 in order to avoid removal of the epitope by cleavage of thepredicted gK signal peptide after aa 24. To provide additional
flexibility in the detection of ORF39p, epitopes were inserted at
both the amino and carboxyl termini of ORF39p—a FLAG
epitope was inserted at its amino terminus (ORF39p-F), and a
cMyc epitope linked to a polyhistidine epitope was inserted at
its carboxyl terminus (ORF39p-M) (Fig. 1A).
To demonstrate that ORF39p and gK could be detected using
the inserted epitopes, ORF39p-F, ORF39p-M and gK-F were
expressed in cultured cells by transfection and immunopreci-
pitated with either anti-FLAG or anti-cMyc MAbs. Upon
resolution by SDS-PAGE, ORF39p-F migrated as a 28 kDa
Fig. 2. Intracellular localization of transiently expressed ORF39p. Cells transfected with ORF39-F were fixed at 16 h post-transfection and incubated with anti-FLAG
MAbs to visualize ORF39p (green), and specific organelle markers that recognized the ER (Grp94-C), Golgi (giantin) or plasma membrane (cell surface biotinylation)
(red).
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species (Fig. 1B). The calculated masses of ORF39p and gK are
27.1 and 38.6 kDa, respectively (Davison and Scott, 1986).Fig. 3. Intracellular localization of transiently expressed gK. Cells transfected with gK
visualize gK (green), and specific organelle markers that recognized the ER (Grp94Therefore, the sizes of the epitope-tagged forms of ORF39p and
gK are in close agreement with their predicated molecular
masses given that the FLAG epitope is expected to add 1 kDa-F were fixed at 16 h post-transfection and incubated with anti-FLAG MAbs to
-C), Golgi (giantin) or plasma membrane (cell surface biotinylation) (red).
Fig. 4. Endo-H sensitivity of transiently expressed gK. Cells were transfected
with plasmids encoding ORF39-F, gB or gK-F or infected with gK-F. Cells were
metabolically labeled and chased in EMEM for 0 h or 4 h; these proteins were
immunoprecipitated using either anti-FLAG or anti-gB MAbs. The proteins
were subjected to endo-H treatment and analyzed by SDS-PAGE (arrows denote
the protein of interest in each panel). (A) gK-F from transfected cells at 0 and 4 h
in either the presence or absence of endo-H. (B) gB at 0 and 4 h in either the
presence or absence of endo-H. (C) ORF39-F at 0 and 4 h in either the presence
or absence of endo-H. (D) gK-F from infected cells at 0 and 4 h in either the
presence or absence of endo-H.
Fig. 5. Intracellular localization of transiently coexpressed gK and ORF39p.
Cells were cotransfected with plasmids that express gK-F and ORF39-M.
Transfected cells were fixed at 16 h after transfection and incubated with either
anti-FLAG antibodies to detect gK (Flag-gK) or anti-6×-his antibodies to detect
ORF39p (His-39). Transfected cells were concurrently incubated with organelle-
specific markers that recognize either the ER (Grp94-C) or Golgi (giantin). For
each experiment, images depicting the overlap between the signals in the first
two panels are shown (merge).
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expected to add approximately 3 kDa. These data confirm that
the inserted epitopes allow the detection of apparently full-
length forms of ORF39p and gK. In addition, the ability of anti-
FLAG MAbs to detect ORF39p-F, in which the FLAG epitope
is at the amino terminus of ORF39p, indicates that ORF39p
does not possess a cleavable N-terminal signal sequence.
Subcellular localization of ORF39p and gK in the absence of
other viral proteins
In order to assess the intracellular distribution of ORF39p
and gK in the absence of other VZV proteins, ORF39p-F and
gK-F were transiently expressed in cultured cells by transfec-
tion. Following fixation and permeabilization, ORF39p-F and
gK-F were identified by indirect immunofluorescence using
anti-FLAG MAbs, and their cellular distributions were
compared to those of Grp94-C and giantin, markers of the
endoplasmic reticulum (ER) and the Golgi, respectively.
ORF39p was diffusely distributed within the cytoplasmic
compartment and largely colocalized with Grp94-C (Fig. 2). It
also appeared in the nuclear envelope, but not within the nu-
cleus itself. No colocalization with giantin was observed. VZV
gK exhibited a similar intracellular distribution, again colo-
calizing primarily with Grp94-C but not with giantin (Fig. 3).
These data indicate that in the absence of other VZV proteins
both ORF39p and gK accumulate predominately in the ER.
In order to determine whether ORF39p and gK traffic to the
plasma membranes of cells in the absence of other VZV
proteins, a surface biotinylation-based method was employed
(Foster et al., 2004b). This method was chosen because boththe N- and C-termini of ORF39p are predicted to be
cytoplasmic based on analogy to its HSV-1 homolog (Foster
et al., 2003; Melancon et al., 2004). For purposes of
comparison, the same method was applied to gK. Live cultured
cells expressing ORF39p-F or gK-F were biotinylated on their
surfaces. Following fixation and permeabilization, the plasma
membranes of the cells were defined by incubation with
streptavidin-conjugated Alexa Fluor 594, and ORF39p-F and
gK-F were identified by indirect immunofluorescence using
anti-FLAG antibodies. When transiently expressed by trans-
fection, neither ORF39p-F nor gK-F colocalized with the
plasma membranes of the cultured cells (Figs. 2 and 3). In
addition, gK was not observed in the plasma membrane of
transfected cells when indirect immunofluorescence was
performed on non-permeabilized cells (data not shown). This
295J. Govero et al. / Virology 358 (2007) 291–302supports the previous data showing that gK does not transit to
the plasma membranes of cells when expressed in isolation
from other VZV proteins. ORF39p was similarly not observed
in the plasma membranes of non-permeabilized cells. However,
this finding is not informative since both the FLAG and cMyc
epitopes incorporated into ORF39p are expected to be
cytoplasmic and, thus, not accessible on the surface of cells
(Foster et al., 2003).
In an effort to confirm our localization data, we performed a
carbohydrate analysis of gK. VZV gK has two N-linked
oligosaccharides in its ectodomain that are processed in the
Golgi from their high mannose (endo-H sensitive) to complex
(endo-H resistant) forms (unpublished data). Thus, acquisition
of endo-H resistance serves as a marker for the transport ofFig. 6. Construction and characterization of recombinant viruses expressing epitope-t
positions of ORF39 and ORF5, which encode gK, are shown (not to scale). The direct
and FLAG epitopes. (B) Cells were infected with VZV ORF39-F, VZV ORF39-M
anti-cMyc antibodies (α-Myc), and gK-F was immunoprecipitated with anti-FLAG
ORF39-F and VZV ORF39-M-infected cells as an infection control. ORF39-F is den
cells were inoculated with native VZV, ORF39-F, ORF39-M or gK-F-infected cells.
MeWo cells. The log10 of the mean number of plaques per dish at each time point. Th
monolayers were infected with similar titers of native VZV, ORF39-F, ORF39-M orglycoproteins from the ER to the Golgi. We found that gK
expressed by transfection remained endo-H sensitive even after
a 4-hour chase, indicating that it had not reached the Golgi
(Fig. 4A; arrow indicates the lower MW, endo-H-cleaved form
of gK). In contrast, transiently expressed VZV gB was endo-H
resistant after a 4-hour chase indicating that it had been
transported to the Golgi (Fig. 4B). As expected, ORF39p,
which has no N-linked glycosylation sites, is unaffected by
treatment with endo-H (Fig. 4C). These data, in combination
with the immunofluorescence-based localization results, suggest
that neither ORF39p-F nor gK are transported beyond the ER
when expressed in the absence of other VZV proteins. However,
gK expressed by infection exhibited endo-H resistance (Fig. 4D;
arrow indicates uncleaved form of gK). Therefore, gK appears toagged gK and ORF39p. (A) The prototype VZV genome is 124,884 bp, and the
ions of translation are indicated (arrow). The black bars indicate the cMyc/6×-his
or VZV gK-F. ORF39p was immunoprecipitated with anti-FLAG (α-FLAG) or
(α-FLAG) MAbs. In addition, gB was immunoprecipitated from both VZV
oted by the asterisk, and ORF39-M and gK-F are denoted by arrows. (C) MeWo
Cells were harvested on days 1–5 after infection, and titers were determined on
e day 0 value is the titer of virus in the VZV-infected cell inocula. (D) MeWo cell
gK-F-infected cells and incubated at 37 °C for 3 days prior to photographing.
Fig. 7. Intracellular localization of ORF39p in infected cells. Cells were infected
with VZV ORF39-F, fixed 72 h after infection and incubated with anti-FLAG
MAbs to detect ORF39p (α-FLAG) and co-incubated with organelle-specific
markers that recognized the ER (Grp94-C), Golgi (giantin) or plasma membrane
(surface).
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examined below.
Transient coexpression of ORF39p and gK does not alter the
subcellular localization of either protein
Previous studies have shown that the HSV-1 UL20 protein
and gK are retained in the ER when expressed alone, but transit
to the Golgi and plasma membrane when expressed together
(Foster et al., 2004b). To investigate if the transport of VZV gK
and ORF39p shares a similar interdependence, ORF39p-M and
gK-F were coexpressed in cultured cells. Upon indirect
immunofluorescence, the intracellular distributions of
ORF39p and gK largely overlapped (Fig. 5, top row). Similar
to the pattern observed when expressed individually, both
ORF39p-M and gK-F colocalized with Grp94-C, but not giantin
indicating that they accumulate primarily in the ER rather than
the Golgi (Fig. 5, bottom four rows). Therefore, within the
sensitivity of this assay, neither ORF39p nor gK appears
sufficient to influence the transport of the other protein.
Construction and characterization of VZV recombinants
expressing epitope-tagged forms of ORF39p and gK
To facilitate the detection of ORF39p and gK during VZV
infection, recombinant viruses that express epitope-tagged
forms of these proteins were generated using cosmid-based
mutagenesis (Cohen and Seidel, 1993). This method is based on
the observation that transfection of susceptible cells with
cosmid clones containing the entire VZV genome in over-
lapping fragments will recombine to produce infectious virus.
To generate a VZV recombinant that expresses ORF39p
containing an N-terminal FLAG epitope, the sequences
encoding native ORF39p in cosmid pvPme19 were replaced
with those encoding ORF39p-F to yield cosmid pvPme19-
FLAG39. This cosmid was then cotransfected with the
remaining three native cosmids into cultured cells. Plaques
were observed 12 days following transfection indicating that
infectious recombinant virus (VZV-ORF39F) had been pro-
duced (Fig. 6A1). The presence of the FLAG epitope coding
sequences in frame with ORF39 in the resulting viral genome
was confirmed by DNA sequencing. A similar method was used
to produce a VZV recombinant expressing ORF39p containing
C-terminal cMyc and poly-His epitopes (VZV-ORF39M), and
the presence of the intended mutation was again confirmed by
DNA sequencing (Fig. 6A2). To generate a VZV recombinant
encoding gK with an N-terminal FLAG epitope (VZV-gKF), the
FLAG epitope coding sequences were inserted into ORF5,
which encodes gK, within cosmid pvFsp4 resulting in cosmid
gK-FLAG/pvFsp4 (Fig. 6A3). These sequences were inserted
into ORF5 after amino acid 31 so that they would not be
removed by cleavage of the signal sequence. Transfection of
gK-FLAG/pvFsp4 with the remaining three native cosmids
again resulted in plaques, indicating that infectious virus had
been produced. The presence of the FLAG epitope coding
sequences in frame with gK in the resulting virus (VZV-gKF)
was confirmed by sequence analysis. Immunoprecipitationsperformed on lysates from cells infected with each of the
recombinant viruses (VZV-ORF39F, VZV-ORF39M or VZV-
gKF) confirmed that anti-FLAG or anti-cMyc antibodies could
detect the epitope-tagged forms of ORF39p and gK (Fig. 6B).
To evaluate whether insertion of the epitopes into ORF39p or
gK affected the ability of VZV to replicate in vitro, the growth
of VZV-ORF39F, VZV-ORF39M and VZV-gKF were com-
pared to that of native VZV during a 5-day growth analysis.
MeWo cells were inoculated with virus-infected cells, and daily
after inoculation, the infected monolayers were harvested and
the virus titers determined. The epitope-tagged recombinant
viruses grew at rates similar to that of native VZV (Fig. 6C). In
addition to the growth rate, plaque morphologies of the epitope-
tagged viruses were compared to native VZV. Cells infected
simultaneously with similar titers of native VZV, VZV-
ORF39F, VZV-ORF39M or VZV-gKF were examined by
light microscopy 72 h after infection. The plaque sizes and
morphologies of the epitope-tagged recombinant viruses were
indistinguishable from those of native VZV (Fig. 6D).
Therefore, insertion of the epitopes into ORF39p and gK did
not alter the growth rate of VZV or impair its ability to spread
between cells.
Intracellular localization of ORF39p and gK during infection
In order to study the intracellular localization of ORF39p and
gK during infection, cultured cells were infected with VZV-
ORF39F or VZV-gKF. Three days after infection, the cells were
fixed and permeabilized, then co-stained with anti-FLAGMAbs
and polyclonal antibodies that recognize either Grp94-C or
giantin, markers of the ER and Golgi, respectively. Upon
Fig. 8. Intracellular localization of gK in infected cells. Cells were infected with
VZV gK-F, fixed 72 h after infection and incubated with anti-FLAG MAbs to
detect gK-F (α-FLAG) and co-incubated with organelle-specific markers that
recognized the ER (Grp94-C), Golgi (giantin) or plasma membrane (surface).
297J. Govero et al. / Virology 358 (2007) 291–302incubation with the appropriate secondary antibodies and
examination by confocal microscopy, intracellular ORF39p
and gK were seen predominately in the Golgi of infected cells
based on their colocalization with giantin (Figs. 7 and 8). These
results demonstrate that both ORF39p and gK traffic differentlyFig. 9. Colocalization of ORF39p and gK with other VZV glycoproteins in infected
stained with anti-FLAG antibodies (α-FLAG) or antibodies specific for selected VZV
processed as in A. For each experiment, images depicting the overlap between the sduring infection than when expressed either individually or
together by transfection, circumstances under which they
localize primarily to the ER (Figs. 2, 3 and 5).
Colocalization of ORF39p and gK with VZV glycoproteins
B, H and E
The observation that ORF39p and gK traffic differently
during infection compared to transfection and that they do not
appear to alter each other's transport suggests that other viral
proteins may mediate their intracellular transport. As a first step
in identifying possible VZV proteins that may influence the
intracellular transport of ORF39p and gK, we examined
whether either of these proteins colocalize with gB, gH or gE,
the three most abundant VZV envelope proteins. Cultured cells
infected with VZV-ORF39F or VZV-gKF were fixed and
permeabilized 3 days post-infection then co-stained with anti-
FLAG polyclonal antibodies and MAbs that recognize VZV
gB, gH or gE. Upon incubation with the appropriate secondary
antibodies and examination by confocal microscopy, both
ORF39p and gK colocalize with each of the glycoproteins
tested, and all appear to reside in a subcellular structure
consistent with the Golgi apparatus (Fig. 9).
The observations that ORF39p and gK both colocalize with
gB, gH and gE during infection and that ORF39p and gK are
not sufficient to alter each other's localization in transient
expression assays raise the possibility that gB, gH or gE
facilitate the export of gK and ORF39p from the ER. To test this
possibility, ORF39p-F and gK-F were coexpressed individually
with gB or gE. When expressed with gB or gE, both ORF39pcells. (A) Cells infected with VZV ORF39-F were fixed 72 h after infection and
glycoproteins (α-gE, α-gB and α-gH). (B) Cells infected with VZV gK-F were
ignals in the first two panels are shown (merge).
Fig. 10. Coexpression of ORF39p or gK with other VZV glycoproteins. (A)
Cells were transfected with plasmids expressing ORF39-F and either gE (first
row) or gB (second row). (B) Cells were transfected with plasmids expressing
gK-F and either gE (third row) or gB (fourth row). For all experiments,
transfected cells were fixed at 16 h after transfection and incubated with either
anti-FLAG antibodies (α-FLAG) to detect either ORF39p (A) or gK (B). The
cells were concurrently incubated with anti-gB (α-gB) or anti-gE (α-gE) MAbs.
For each experiment, images depicting the overlap between the signals in the
first two panels are shown (merge).
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gB or gE alone are insufficient to direct ORF39p or gK to the
Golgi (Fig. 10).
Discussion
In this study, we examined the intracellular transport of VZV
ORF39p and gK. We found that both ORF39p and gK
accumulate primarily in the Golgi and to a lesser extent the
plasma membrane of infected cells. When expressed individ-
ually, however, they fail to translocate beyond the ER,
indicating that one or more, as yet undefined, VZV proteins
are required for their intracellular transport.
Both ORF39p and gK are conserved among the alphaher-
pesviruses (Cohen and Straus, 1996; Davison and Scott, 1986;
Roizman, 1990). It has previously been shown that the transport
of HSV-1 gK and UL20 protein (the homolog of VZV ORF39p)
beyond the ER depends on the expression of both proteins. In
particular, the HSV UL20 protein is necessary for the Golgi-
dependent glycosylation and cell surface expression of gK
(Avitabile et al., 1994; Dietz et al., 2000; Foster et al., 2004b). In
contrast, however, VZV ORF39p and gK remain in the ER even
when these proteins are coexpressed. Thus, our data failed todemonstrate a similar interdependence of VZV ORF39p and gK
for their intracellular transport as had been seen in HSV-1. This
suggests that other VZV proteins mediate the intracellular
trafficking of ORF39p and gK, leading ultimately to their
distribution in the Golgi and plasma membranes of infected
cells.
The biological importance of this functional divergence
between VZV and HSV-1 is not known. Deletions in either
UL20 protein or gK in both HSV and PrV result in the
accumulation of nonenveloped capsids within the cytoplasm of
infected cells, indicating that the proteins function during the
cytoplasmic stages of virion envelopment. They may, for
example, play a role in either secondary envelopment of
cytoplasmic capsids or the prevention of aberrant de-envelop-
ment from cytoplasmic vesicles (Dolter et al., 1994; Foster and
Kousoulas, 1999; Fuchs et al., 1997; Jayachandra et al., 1997;
Mo et al., 1999; Ward et al., 1994). In addition, UL20 protein is
necessary for virus-induced cell fusion caused by syncytial
mutations in either gB or gK (Avitabile et al., 2004). All of these
data suggest that UL20 protein and gK play important roles in
regulating membrane fusion associated with viral egress and
virus-induced cell fusion. The extreme cell association of VZV
highlights differences between its egress pathway and that of
most other alphaherpesviruses, which release abundant infec-
tious cell free virions. It is tempting to speculate that functional
dissimilarities between these proteins and their HSV-1 homo-
logs may play a role in the distinct VZV egress pathway.
The inability of ORF39p and gK to escape the ER without
the intervention of other VZV proteins is in itself somewhat
unexpected since neither protein possesses known ER retention
signals. Moreover, both contain YXXϕ motifs that would be
expected to direct their accumulation in the Golgi. The
membrane topology of neither VZV gK nor ORF39p is
known. However, if their topologies are analogous to those of
their HSV-1 homologs, these YXXϕ motifs would be expected
to be exposed to the cytoplasm where they would be available to
interact with the cellular transport machinery. Nonetheless, the
localization of VZV ORF39p and gK to the Golgi of infected
cells has implications for the functions of these proteins.
Perhaps most importantly, since VZV is believed to acquire its
final envelope from Golgi-derived vesicles, the accumulation of
ORF39p and gK in the Golgi raises the possibility that these
proteins are incorporated into the virion envelope along with
gB, gH and gE. HSV-1 gK and UL20 have been shown to be
present in the virion envelope (Foster and Kousoulas, 1999;
Foster et al., 2001, 2003).
For a number of reasons, other VZV encoded glycoproteins
seemed to be likely candidates as mediators of ORF39p and gK
transport. First, all alphaherpesvirus glycoproteins are trans-
ported to the Golgi and the plasma membrane (Mettenleiter,
2002; Roizman, 1990; Ward et al., 1994). Second, examples
exist of VZV glycoproteins whose transport is influenced by
direct interactions with other glycoproteins, such as gH/gL and
gE/gI (Alconada et al., 1998; Cai et al., 1988; Claesson-Welsh
and Spear, 1986; Hutchinson et al., 1992a; Kari et al., 1992;
Klupp et al., 1994; Montalvo and Grose, 1987; Whealy et al.,
1990, 1992; Whitbeck et al., 1996). Third, at least one VZV
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(Heineman and Hall, 2002). As an initial step in testing this
hypothesis, we showed that both ORF39p and gK tightly
colocalize with several other abundantly expressed VZV
glycoproteins, namely gB, gH and gE, in infected cells.
Additional coexpression experiments, however, showed that
gB and gE had no effect on the intracellular localization of
VZV ORF39p or gK. Thus, the identity of the VZV protein(s)
that determine the infected cell localization of VZV ORF39p
and gK remains unknown. It is, of course, possible that one or
more of the membrane proteins already tested participate in
the intracellular trafficking of ORF39p or gK but that this
effect was not observed because additional proteins are also
required.
ORF39p and gK are both highly hydrophobic, and studies of
these proteins have been hampered by the inability to produce
high quality antibodies presumably for this reason. In this study,
we have generated both amino and carboxy terminal epitope-
tagged forms of ORF39p allowing flexibility to study the
proteins. The ability to detect ORF39-F indicates that ORF39
does not possess a cleavable N-terminal signal sequence,
suggesting that it is not a type I membrane protein. The data
provided here demonstrate the utility of epitope-tagged viruses
to study VZV gK and ORF39p. In neither case did the addition
of an epitope tag noticeably affect the growth rate or
morphology of the mutant viruses. The epitope-tagged forms
of these viruses will allow future studies including more defined
examinations of the topology of ORF39p and gK and an
examination of their interactions with other VZV or cellular
proteins.
Materials and methods
Cell culture and virus propagation
MeWo cells, an immortalized human melanoma cell line,
were grown in Eagle's minimum essential medium (EMEM)
containing 10% fetal bovine serum (FBS; Bio-Whittaker) and
GASP (2 mM L-glutamine, chlorotetracycline, penicillin and
streptomycin; Quality Biological). BSC-40, an African green
monkey kidney cell line (ATCC), were grown in EMEM
containing 10% FBS and GASP. Recombinant vaccinia virus
vTF7-3 was obtained from the ATCC, and viral stocks were
prepared and titered in BSC-40 cells. VZV was propagated in
MeWo cells.
Immune reagents and intracellular markers
Anti-FLAG M2 monoclonal antibodies (MAbs) and anti-
FLAG M2 MAbs conjugated to fluorescein isothiocyanate
(FITC) were purchased from Sigma. Anti-polyhistidine MAbs
were purchased from R&D Systems. Anti-cMyc and anti-
giantin polyclonal antibodies (PAbs) were purchased from
Covance Research Products. Anti-Grp94-C PAbs were pro-
vided by Dr. Michael Green (Saint Louis University). Tetra-
methylrhodamine isothiocyanate (TRITC) conjugated to wheat
germ agglutinin (WGA) was purchased from EY Laboratories.Goat anti-mouse and anti-rabbit IgG MAbs conjugated to FITC
were purchased from Sigma. Goat anti-mouse IgG MAbs Abs
conjugated with Alexa Fluor 488, goat anti-rabbit IgG PAbs
conjugated with Alexa Fluor 568 and streptavidin-conjugated
with Alexa Fluor 594 were purchased from Molecular Probes.
Anti-VZV gB and gE MAbs were purchased from Biodesign
International. EZ-Link Sulfo-NHS-LC-Biotin was purchased
from Pierce Chemicals.
Plasmid construction
To generate an expression plasmid that encodes ORF39 with
a FLAG epitope at its amino terminus, VZV ORF39 was
amplified by PCR and inserted into pFLAG-CMV2 (Kodak)
downstream of, and in frame with, the FLAG epitope
(MDYKDDDDK) coding sequence present within this vector
to yield pFLAG-CMV2-ORF39. The sequences encoding
ORF39p/FLAG were amplified by PCR of pFLAG-CMV2-
ORF39 and inserted into pBluescript II-SK+ (Stratagene)
downstream of the T7 promoter to yield pBS-39FLAG. To
generate an expression plasmid that encodes ORF39 with a
cMyc epitope at its carboxy terminus, VZV ORF39 was
amplified by PCR and inserted into pCDNA3.1A (Invitrogen)
upstream of, and in frame with, the cMyc (EQKLISEEDL) and
polyhistidine (HHHHHH) epitope coding sequences present
within this vector to yield pCDNA-ORF39Myc. To generate an
expression plasmid that encodes gK with a FLAG epitope near
its carboxy terminus, VZV ORF5, which encodes gK, was
amplified by PCR and inserted into pBluescript II-SK
downstream of the T7 promoter to yield pBS-gK, and the
FLAG epitope-coding sequence was introduced into this
plasmid by site-directed mutagenesis after the codon for gK
amino acid 31 to yield pBS-gKFLAG.
Production of recombinant VZV
Recombinant virus was generated using four overlapping
cosmid vectors that span the VZV genome: pvFsp4 (nucleotides
1–33,211), pvSpe5 (nucleotides 21,875–62,008), pvPme19
(nucleotides 53,877–96,188) and pvSpe21 (nucleotides 94,208–
124,884) (Kemble et al., 2000). To produce cosmid pvPme19-
FLAG39 that encodes ORF39p containing a FLAG epitope at its
N-terminus, pvPme19 was cut with NotI and AvrII, and the
resulting 9433 bp fragment (VZV nucleotides 62,860–72,293),
which contains ORF39 (VZV nucleotides 70,633–71,352), was
isolated. This fragment was cloned into pBluescript II-KS+
(Stratagene) in which the SmaI site had been replaced by an AvrII
site and the EcoRV site had been eliminated, to yield
pBSAvrΔEcoRV-9433. A 2886 bp EcoRV/XbaI fragment contain-
ing ORF39 was excised from this plasmid and cloned into
pBluescript II-SK+ to yield pBS-2886. ORF39 was removed from
pBS-2886, and the ORF39FLAG coding sequences from pFLAG-
CMV2-ORF39 were inserted in place of native ORF39 to yield
pBS-2886ORF39FLAG. VZV sequences containing ORF39-
FLAG were subsequently excised from pBS-2886ORF39FLAG
and cloned into pBSAvrΔEcoRV-9433 from which the
corresponding VZV sequences had been removed. The NotI/
300 J. Govero et al. / Virology 358 (2007) 291–302AvrII fragment from this construct was inserted into pvPme19 to
yield pvPme19-FLAG39.
A similar cloning strategy was used to produce cosmid
pvPme19-Myc39. Using pBS-2886 as the template, ORF39 was
amplified by PCR with NheI and HindIII ends, and the resulting
792 bp fragment was cloned into the NheI and HindIII sites of
pCDNA3.1 (Invitrogen) to introduce cMyc and 6×-his epitope
coding sequences in frame at the 3′ end of ORF39 (pCDNA-
ORF39). ORF39 incorporating the cMyc and 6×-his epitope
coding sequences was substituted into the VZV cosmid
pvPme19 using the above cloning strategy to yield cosmid
pvPme19-Myc39.
ORF5, which codes for gK, spans nucleotides 5274–4252
and is contained within VZV cosmid pvFsp4. A 3919 bp
fragment (nucleotides 8205–4286) that contains all but the 3′
terminal 34 bp of ORF5 was excised from pvFsp4 by HindIII
digestion. This fragment was cloned into pBluescript II-KS+ to
yield pBS-gK3919. The FLAG epitope coding sequences, as
well as an XhoI site for screening purposes, were introduced
into the resulting construct after gK codon 31 by site-directed
mutagenesis. ORF5 containing the FLAG epitope coding
sequences was then excised by digestion with HindIII and
reintroduced into pvFsp4 in place of native ORF5 to yield
cosmid pvFsp4/ORF5-FLAG.
To produce recombinant virus, the method of Mallory et al.
(1997) was used Briefly, 60-mm-diameter dishes were seeded
with 1×106 MeWo cells 1 day prior to transfection. Transfec-
tions were performed using calcium phosphate precipitates
(CalPhos Mammalian Transfection Kit; Clontech). The cosmids
were linearized with AscI, and the enzyme heat inactivated,
prior to transfection. Each transfection mixture contained 1.5 μg
of pvSpe21 and 3 μg of each of the remaining cosmids. Five
days after transfection, the cells were seeded into 75-cm2 flasks
and monitored for cytopathic effects (CPE).
Growth characteristics of VZV
VZV titers were determined by inoculating MeWo cells with
serial 10-fold dilutions of virus-infected cells. VZVgrowth curves
were generated by inoculating MeWo cells with approximately
100 plaque-forming units (pfu) of infected cells per 25 cm2 flask
(day 0). The cells in individual flasks were treated with trypsin,
and the virus titer determined at days 1 to 5 after infection (Cohen
and Seidel, 1993; Heineman and Hall, 2002).
To compare plaque morphologies, cultured cells were
inoculated with similar titers of cells infected with either native
VZV or VZV expressing the epitope-tagged forms of ORF39p
or gK, incubated at 37 °C for 4 days and then photographed
through an inverted light microscope.
Expression of ORF39p and gK by transfection and infection
ORF39p and gK were expressed in vitro using the vaccinia
T7 expression system (Fuerst et al., 1986). Cells at 75–90%
confluence were infected with recombinant vaccinia virus
vTF7-3 at a multiplicity of infection of 10 then transfected with
4 μg of purified DNA (Qiagen) using 10 μl of Lipofectamine2000 (Invitrogen) in 10 cm2 wells or 2 μg of DNA and 5 μl of
Lipofectamine 2000 in 1.2 cm2 wells. Cells were incubated at
37 °C and 5% CO2 for 16 h prior to metabolic labeling or
fluorescent staining. To express ORF39p and gK during
infection, cultured cells were inoculated with VZV-infected
cells and incubated at 37 °C in 5% CO2 prior to processing.
Radiolabeling and immunoprecipitation
Metabolic radiolabeling and immunoprecipitations were
performed as previously described (Heineman and Hall,
2002). Briefly, ORF39p or gK expressed in cultured cells by
transfection was metabolically labeled 16 h after transfection,
and VZV-infected cells were labeled when extensive 2–3+ CPE
was observed, typically 3–4 days following infection. Cells
were incubated for 1 h in EMEM lacking cysteine and
methionine and then incubated in Cys- and Met-free EMEM
containing 125 μCi of Tran35S-label (ICN) per ml for 4 h.
Labeled cells were washed and lysed in phosphate-buffered
saline (PBS) containing 1% Triton X-100, 0.5% deoxycholate
and 0.1% sodium dodecyl sulfate (SDS). VZV gK and ORF39p
were immunoprecipitated by incubating the labeled cell lysates
with anti-FLAG or anti-cMyc MAbs (1:750 dilution) overnight
at 4 °C followed by incubation with Staphylococcus protein
G–sepharose (Pharmacia-Biotech) for 1 h at 4 °C. After
washing, immunoprecipitated proteins were eluted in sample
buffer containing 2% SDS and 40 mM dithiothreitol (DTT)
and resolved by SDS-polyacrylamide gel electrophoresis
(PAGE). The immunoprecipitated proteins were visualized
by autoradiography.
Carbohydrate analysis
VZV ORF39p, gK or gB was expressed by transfection or
infection and metabolically radiolabeled as described above
except that the cells were incubated for 1 h in EMEM lacking
cysteine and methionine prior to the addition of Tran35S-label.
They were incubated with the labeling medium for 1 h. At that
time, they were either lysed immediately (0 h chase) or they
were incubated with chase medium (EMEM containing 10%
FBS, 24 μg/ml cysteine and 15 μg/ml methionine) for 4 h prior
to lysis (4 h chase). ORF39p, gK or gB was immunoprecipitated
using anti-FLAG or anti-gB MAbs as described above. In some
cases, the immunoprecipitated proteins were treated with
endoglycosidase H (endo-H). To do so, Staphylococcus protein
G–sepharose-bound proteins were heated to 98 °C for 3 min in
10 μl of 0.2% SDS-50 mM Tris–HCl (pH 6.8). After cooling to
room temperature, 10 μl of 0.15 M sodium citrate (pH 5.3) and
1 μl of endo-H (Roche) were added, and the reaction mixtures
were incubated overnight at 37 °C. Sample buffer was added to
the immunoprecipitated proteins, and they were resolved by
10% SDS-PAGE.
Immunofluorescence and confocal microscopy
To evaluate the intracellular localization of ORF39p and gK,
infected or transfected cells were fixed and permeabilized in 4%
301J. Govero et al. / Virology 358 (2007) 291–302paraformaldehyde/0.2% Triton X-100 for 1 h at 4 °C. Following
fixation, cells were incubated with Image-it signal enhancer
(Molecular Probes) for 15 min at room temperature and then
incubated for 1 h with the appropriate primary antibodies. The
cells were then washed in PBS and incubated for 1 h at RT with
secondary antibodies conjugated to a fluorescent marker. In some
colocalization experiments, WGA-TRITC (5 μg/ml in PBS) was
incubated with the fixed cells for 20 min concurrently with the
secondary antibodies. After washing in PBS, the cells were
viewedwith a Bio-RadMRC1024 scanning confocalmicroscope.
To evaluate the plasma membrane localization of ORF39p
and gK, infected or transfected cells were washed with PBS and
incubated for 30 min at RT in 10 mM EZ-Link Sulfo-NHS-LC-
Biotin (Pierce Chemicals) prior to fixation and permeabilization
in 4% paraformaldehyde/0.2% Triton X-100 as above. The
biotinylated cells were incubated with streptavidin-conjugated
Alexa Fluor 594 (1:1000 in PBS) for 1 h at RT. Immunoflu-
orescence was visualized using a Bio-Rad 1024 laser confocal
microscope.References
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